Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

Novel approach allows researchers to define how cells in the retina respond to diabetes

Novel approach allows researchers to define how cells in the retina respond to diabetes

Study: aPKC inhibitors may provide new therapeutic option for blinding eye diseases

Study: aPKC inhibitors may provide new therapeutic option for blinding eye diseases

New system that uses AI accurately detects patients with diabetic retinopathy

New system that uses AI accurately detects patients with diabetic retinopathy

Connection between Alzheimer’s disease and degenerative eye diseases

Connection between Alzheimer’s disease and degenerative eye diseases

Study finds link between degenerative eye conditions and Alzheimer's disease

Study finds link between degenerative eye conditions and Alzheimer's disease

Saving sight of millions by making eye injections safe and comfortable

Saving sight of millions by making eye injections safe and comfortable

Progesterone and lipoic acid combination ameliorates death of photoreceptors in the retina

Progesterone and lipoic acid combination ameliorates death of photoreceptors in the retina

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Johns Hopkins researchers reveal potential of AI in medical imaging and diagnostics

Johns Hopkins researchers reveal potential of AI in medical imaging and diagnostics

Persistent psychological stress contributes to development and progression of vision loss

Persistent psychological stress contributes to development and progression of vision loss

Microglia play  protective role in response to retinal detachment, shows study

Microglia play protective role in response to retinal detachment, shows study

People with type 1 diabetes for decades show signs of mild drop in cognitive abilities

People with type 1 diabetes for decades show signs of mild drop in cognitive abilities

Limited health literacy blocks heart disease prevention and treatment

Limited health literacy blocks heart disease prevention and treatment

Unique imaging technique identifies biomarkers of cellular damage done by diabetic retinopathy

Unique imaging technique identifies biomarkers of cellular damage done by diabetic retinopathy

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

Siemens Healthineers and Hill-Rom join to provide comprehensive solutions for primary diabetes care

Siemens Healthineers and Hill-Rom join to provide comprehensive solutions for primary diabetes care

MU researchers use new techniques to fight against diabetic retinopathy

MU researchers use new techniques to fight against diabetic retinopathy